223671-64-5 Usage
Chemical compound
A substance formed by a chemical reaction, with a specific molecular structure and properties.
Potential use
As a fluorescent probe in biological and medical research.
Derivative of isoquinoline
A heterocyclic aromatic compound with a unique structure and properties.
Presence of a chlorine atom
Adds unique properties to the compound, such as increased reactivity and the ability to form covalent bonds with other molecules.
Presence of a hydroxymethyl group
A functional group that contributes to the compound's solubility, reactivity, and ability to form hydrogen bonds with other molecules.
Fluorescence properties
The compound emits light when excited by a specific wavelength, making it useful for imaging and labeling applications.
Interaction with biomolecules
The compound can bind to specific molecular targets in cells and tissues, allowing for the study of biological processes and the detection of specific targets.
Promising candidate
Due to its unique properties, it has potential for further development and use in various applications.
Structural features
The compound's structure can be modified through chemical reactions to tailor its properties for specific applications.
Suitability for further chemical modifications
The compound's structure can be altered to enhance its properties or adapt it for different uses in biological and medical research.
Check Digit Verification of cas no
The CAS Registry Mumber 223671-64-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,3,6,7 and 1 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 223671-64:
(8*2)+(7*2)+(6*3)+(5*6)+(4*7)+(3*1)+(2*6)+(1*4)=125
125 % 10 = 5
So 223671-64-5 is a valid CAS Registry Number.
223671-64-5Relevant articles and documents
Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 3: 1-Isoquinolinylguanidines
Barber, Christopher G.,Dickinson, Roger P.,Fish, Paul V.
, p. 3227 - 3230 (2007/10/03)
A series of 1-isoquinolinylguanidines are shown to be potent inhibitors of uPA with selectivity over tPA and plasmin. Potency is enhanced by the presence of a 4-halo and a 7-aryl substituent, particularly when substituted by a 3-carboxylic acid group. Compound 13j (UK-356,202) combines excellent potency and selectivity, and has been selected as a candidate for clinical evaluation.
